Stephen F. Betz, Chief Scientific Officer of Crinetics Pharmaceuticals ($CRNX), sold about $3.34 million worth of company shares in three open market transactions over the past year, with his most recent sale on June 12, 2025. These sales rank him 2,527th among 11,678 insiders by total value sold, below the average of $8.59 million across about 6.4 transactions per insider. Betz made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 6371 | $37.11 | 141,342.0000 | 94,548,000 | 4.31% | 0.01% |
| March 16, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 4241 | $37.77 | 137,101.0000 | 94,548,000 | 3.00% | 0.00% |
| Feb. 23, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | A | Common Stock | 30000 | $0.00 | 147,713.0000 | 94,548,000 | 25.49% | 0.03% |
| Feb. 23, 2026 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 47000 | $0.00 | 47,000.0000 | 94,548,000 | 9999.99% | 0.05% |
| Dec. 26, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 90,514.0000 | 94,548,000 | 16.59% | 0.02% |
| Dec. 26, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | M | Common Stock | 18000 | $1.91 | 117,713.0000 | 94,548,000 | 18.05% | 0.02% |
| June 12, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 97483 | $32.23 | 99,713.0000 | 92,926,000 | 49.43% | 0.10% |
| June 12, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 71525 | $0.00 | 108,514.0000 | 92,926,000 | 39.73% | 0.08% |
| June 12, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 16645 | $0.00 | 58,198.0000 | 92,926,000 | 22.24% | 0.02% |
| June 12, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | M | Common Stock | 71525 | $1.91 | 180,551.0000 | 92,926,000 | 65.60% | 0.08% |
| June 12, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | M | Common Stock | 16645 | $9.28 | 197,196.0000 | 92,926,000 | 9.22% | 0.02% |
| March 19, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 5479 | $34.17 | 108,879.0000 | 92,926,000 | 4.79% | 0.01% |
| March 19, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 291 | $34.83 | 108,588.0000 | 92,926,000 | 0.27% | 0.00% |
| Feb. 20, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | A | Common Stock | 43000 | $0.00 | 114,358.0000 | 92,926,000 | 60.26% | 0.05% |
| Feb. 20, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 92,926,000 | 9999.99% | 0.07% |
| Nov. 20, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | J | Common Stock | 451 | $14.98 | 71,358.0000 | 68,175,000 | 0.64% | 0.00% |
| Dec. 16, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | M | Common Stock | 2331 | $1.91 | 71,358.0000 | 68,175,000 | 3.38% | 0.00% |
| Dec. 16, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 2331 | $0.00 | 180,039.0000 | 68,175,000 | 1.28% | 0.00% |
| Sept. 10, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 1035 | $51.50 | 68,576.0000 | 68,175,000 | 1.49% | 0.00% |
| Aug. 26, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $53.19 | 69,611.0000 | 68,175,000 | 4.13% | 0.00% |
| Aug. 12, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $47.68 | 72,611.0000 | 68,175,000 | 3.97% | 0.00% |
| July 25, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $53.43 | 75,611.0000 | 68,175,000 | 3.82% | 0.00% |
| July 10, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $48.55 | 78,611.0000 | 68,175,000 | 3.68% | 0.00% |
| June 25, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $45.37 | 80,643.0000 | 68,175,000 | 3.59% | 0.00% |
| June 10, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $43.86 | 83,643.0000 | 68,175,000 | 3.46% | 0.00% |
| May 28, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $47.49 | 86,643.0000 | 68,175,000 | 3.35% | 0.00% |
| May 10, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $49.43 | 89,643.0000 | 68,175,000 | 3.24% | 0.00% |
| March 18, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | F | Common Stock | 3655 | $38.14 | 92,643.0000 | 68,175,000 | 3.80% | 0.01% |
| March 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | A | Stock Option (right to buy) | 87000 | $0.00 | 87,000.0000 | 68,175,000 | 9999.99% | 0.13% |
| March 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | A | Common Stock | 23000 | $0.00 | 96,298.0000 | 68,175,000 | 31.38% | 0.03% |
| Jan. 25, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $37.26 | 73,298.0000 | 68,175,000 | 3.93% | 0.00% |
| Jan. 10, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $37.65 | 76,298.0000 | 68,175,000 | 3.78% | 0.00% |
| Dec. 26, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $35.89 | 79,298.0000 | 32,344,371,000 | 3.65% | 0.00% |
| Dec. 11, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $32.87 | 82,298.0000 | 32,344,371,000 | 3.52% | 0.00% |
| Nov. 27, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $31.84 | 85,298.0000 | 32,344,371,000 | 3.40% | 0.00% |
| March 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | F | Common Stock | 1410 | $17.12 | 86,879.0000 | 0 | 1.60% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | A | Stock Option (right to buy) | 110000 | $0.00 | 110,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | A | Common Stock | 23600 | $0.00 | 88,289.0000 | 0 | 36.48% | 0.00% |
| Feb. 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3126 | $19.59 | 64,689.0000 | 0 | 4.61% | 0.00% |
| Jan. 25, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 8336 | $21.07 | 67,815.0000 | 0 | 10.95% | 0.00% |
| Jan. 17, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3126 | $18.00 | 76,151.0000 | 0 | 3.94% | 0.00% |
| Jan. 3, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3126 | $18.35 | 79,277.0000 | 0 | 3.79% | 0.00% |